Carregant...
Evaluation of the COVID19 ID NOW EUA assay
BACKGROUND: The SARS-CoV-2 pandemic caused a major surge in needed diagnostic capacity. In response, many EUA assays have become available for clinical laboratories, and more recently, the point of care device, Abbott ID NOW. OBJECTIVES: To determine the analytical performance of the ID NOW assay fo...
Guardat en:
| Publicat a: | J Clin Virol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier B.V.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7227587/ https://ncbi.nlm.nih.gov/pubmed/32425657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcv.2020.104429 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|